Physician

Aaron Weisbord, M.D.

According to 2025 Medicare claims, Aaron Weisbord, M.D. (NPI: 1063638096) practices cardiology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Washington, RI. This provider's primary affiliated billing organization is LIFESPAN PHYSICIAN GROUP, INC. (NPI: 1407116643; TIN: 05-0389801) and primary practice location at 02879-8271. Weisbord is affiliated with the Lifespan Health Alliance, LLC (ACO ID: A3336) and RIPC Population Management LLC (ACO ID: A5561), participating under the MSSP model.

Weisbord's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,166 traditional Medicare patients, billed 2,198 HCPCS/CPT codes, and received $86,673 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 7,823 prescription claims across 963 beneficiaries totaling $2,076,603 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 16 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $208,845 to $2,076,603. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,040	2,585	$110,180
2016	1,103	2,826	$119,875
2017	1,149	2,941	$121,004
2018	1,214	3,047	$122,791
2019	1,214	3,151	$128,877
2020	1,105	2,645	$105,777
2021	1,156	3,071	$135,739
2022	1,124	2,806	$103,575
2023	1,128	2,739	$106,086
2024	1,166	2,198	$86,673

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	453	4,497	$208,845
2016	502	5,532	$273,802
2017	566	6,302	$362,417
2018	630	6,590	$464,669
2019	659	6,704	$608,813
2020	706	7,088	$789,782
2021	730	7,498	$1,017,560
2022	839	8,084	$1,270,977
2023	921	8,509	$1,636,921
2024	963	7,823	$2,076,603

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	16	$29,315
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	107	107	$103
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	225	225	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	288	334	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	170	177	$50
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	773	875	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,068	49,496	$938,853
Vyndamax	Tafamidis	22	720	$512,388
Xarelto	Rivaroxaban	195	11,010	$196,958
Entresto	Sacubitril/Valsartan	122	5,243	$116,055
Repatha Sureclick	Evolocumab	95	4,690	$90,491

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aaron Weisbord, M.D.?

Tedicare shows public-source Medicare data for Aaron Weisbord, M.D. (NPI 1063638096), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Weisbord, M.D. have ACO affiliation data?

Aaron Weisbord, M.D. is shown with ACO affiliation data for Lifespan Health Alliance, LLC (MSSP, ACO ID A3336) and RIPC Population Management LLC (MSSP, ACO ID A5561).

What billing organization is linked to Aaron Weisbord, M.D.?

Aaron Weisbord, M.D. is linked to LIFESPAN PHYSICIAN GROUP, INC. (billing NPI 1407116643) in the available physician profile data.

Does Aaron Weisbord, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.